Features of mitochondrial membrane potential of immunocompetent blood cells in children with chronic nonspecific lung diseases accompanied by pneumofibrosis

Pneumofibrosis is a pathological outcome of pulmonary tissue inflammation. It can complicate any lung and bronchial disorder. The mitochondrial membrane potential reflects functional state of immunocompetent blood cells that influence progression of a chronic inflammatory process. The aim of this work was to study the features of mitochondrial membrane potential (MMP) of immunocompetent blood cells in children with chronic nonspecific lung diseases (CNPD), accompanied by pneumofibrosis. We have examined 79 children with CNPD manifesting with symptoms of focal pneumofibrosis. The group of patients included children with congenital lung malformations (43%), consequences of bronchopulmonary dysplasia (41%), chronic bronchitis (10%), post-pneumonic pulmonary fibrosis (6%). The average age of children was 6.5±1.2 years, including 43 boys (54%) and 36 girls (46%). The comparison group included 46 children with COPD without signs of pulmonary fibrosis, the control group consisted of 30 apparently healthy children. The contents of cells with reduced MMP among lymphocytes, monocytes, and granulocytes in peripheral blood was determined with JC-1 dye, using the BD FACSCalibur instrument and Cell Quest Pro software (Becton Dickinson, USA). The proportion of lymphocytes with reduced MMP in patients with COPD was similar in the children of the main and comparison group, exceeding the indexes of the control group by 1.7 times (p < 0.001). Decreased MMP of granulocytes in children with pneumofibrosis was detected 1.9 times more often than in children with fibrosis-free CNPD cases (p < 0.05), and 3.4 times more common than in children from the control group (p < 0.001). Monocytes with reduced MMM in children with pulmonary fibrosis were detected 2 times more often than in children with COPD without fibrosis (p < 0.05), and 7.3 times more frequent than in the control group (p < 0.001). The changes were more expressed in children during exacerbation of the disease. The revealed features suggest a decreased level of metabolic activity of blood cells, thus, probably, presenting an immunopathogenetic basis for development of pneumofibrosis.

1. Denisenko Yu.K., Novgorodtseva T.P., Vitkina T.I., Antonyuk M.V., Zhukova N.V. Mitochondrial dysfunction in chronic obstructive pulmonary disease. Byulleten fiziologii i patologii dykhaniya = Bulletin of Physiology and Pathology of Respiration, 2016, Iss. 60, pp. 28-33. (In Russ.)

2. Dolgushin I.I., Mezentseva E.A., Savochkina A.Yu., Kuznetsova E.K. Neutrophil as a multifunctional relay in immune system. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2019, Vol. 9, no. 1, pp. 9-38. (In Russ.) doi: 10.15789/2220-7619-2019-1-9-38

3. Evseeva G.P., Iakovlev E.I., Lebed’ko O.A., Kuznetsova M.S., Pichugina S.V., Kuderova N.I., Sirina T.S., Varakina V.L., Kozlov V.K. The diagnostics of cell energetic deficit in children with chronic bronchopulmonary pathology. Byulleten fiziologii i patologii dykhaniya = Bulletin of Physiology and Pathology of Respiration, 2018, Iss. 68, pp. 46-51. (In Russ.)

4. Ihnatovich T.V., Zafranskaya M.M. The immunopathogenesis of fibrosis. Immunopatologiya, allergologiya, infektologiya = Immunopathology, Allergology, Infectology, 2019, no. 1, pp. 6-17. (In Russ.)

5. Lebedeva A.I., Muslimov S.A., Musina L.A. Experimental modeling of the chronic inflammation process and fibrosis. Biomeditsina = Biomedicine, 2013, no. 4, pp. 114-123. (In Russ.)

6. Maianski N.A. Neutrophil mitochondria: features of physiology and significance in apoptosis. Immunologiya = Immunologiya, 2004, Vol. 5, no. 5, pp. 307-311. (In Russ.)

7. Savchenko A.A., Borisov A.G., Modestov A.A., Moshev A.V., Kudryavtsev I.V., Tonacheva O.G., Koshcheev V.N. Monocytes subpopulations and chemiluminescent activity in patients with renal cell carcinoma. Meditsinskaya immunologiya = Medical Immunology (Russia), 2015, Vol. 17, no. 2, pp. 141-150. (In Russ.) doi: 10.15789/1563-0625-2015-2-141-150.

8. Frelikh G.A., Polomeeva N.U., Vasil’ev A.S., Udut V.V. State of the art methods of evaluation of mitochondrial function. Sibirskiy zhurnal klinicheskoy i eksperimentalnoy meditsiny = Siberian Journal of Clinical and Experimental Medicine, 2013, Vol. 28, no. 3, pp. 7-13. (In Russ.)

9. Khorinko A.V., Amarantov D.G., Kosareva P.V. The role of the disorders of cell matrix interactions in the pathogenesis of pulmonary fibrosis progression. Zhurnal anatomii i gistopatologii = Journal of Anatomy and Histopathology, 2016, Vol. 5, no. 31, pp. 84-89. (In Russ.)

10. Aravamudan B., Thompson M.A., Pabelick C.M., Prakash Y.S. Mitochondria in lung diseases. Expert Rev. Respir. Med., 2013, Vol. 7, no. 5. pp. 631-646.

11. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochem. J., 2011, Vol. 435, pp. 297-312.

12. Drakopanagiotakis F., Xiſteri A., Polychronopoulos V., Bouros D. Apoptosis in lung injury and fibrosis. Eur. Respir. J., 2008, Vol. 32. рр. 1631-1638.

13. Hao W., Marsh C., Friedman A. A mathematical model of idiopathic pulmonary fibrosis. PLoS One, 2015, Vol. 10, no. 9, e0135097. doi: 10.1371/journal.pone.0135097.

14. Prakash Y.S., Pabelick C.M., Sieck G.C. Mitochondrial dysfunction in airway disease. CHEST, 2017, Vol.152, no. 3. рр. 618-626.

15. Widlansky M.E., Wang J., Shenouda S.M., Hagen T.M., Smith A.R., Kizhakekuttu T.J., Kluge M.A., Weihrauch D., Gutterman D.D., Vita J.A. Altered mitochondrial membrane potential, mass, and morphology in the mononuclear cells of humans with type 2 diabetes. Transl. Res, 2010, Vol. 156, no. 1, рр. 15-25.